Chemoinformaics analysis of 7-(3,4-DIMETHOXYPHENYL)-[1,3]DIOXOLO[4,5-H]CHROMEN-6-ONE
| Molecular Weight | 326.304 | nRot | 3 |
| Heavy Atom Molecular Weight | 312.192 | nRig | 22 |
| Exact Molecular Weight | 326.079 | nRing | 4 |
| Solubility: LogS | -4.732 | nHRing | 2 |
| Solubility: LogP | 2.954 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 44.2071 |
| nHD | 0 | BPOL | 23.5929 |
| QED | 0.736 |
| Synth | 2.373 |
| Natural Product Likeliness | 0.706 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.549 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.631 |
| MDCK | 0.0000531 |
| BBB | 0.104 |
| PPB | 0.904572 |
| VDSS | 0.476 |
| FU | 0.0650378 |
| CYP1A2-inh | 0.96 |
| CYP1A2-sub | 0.781 |
| CYP2c19-inh | 0.957 |
| CYP2c19-sub | 0.136 |
| CYP2c9-inh | 0.849 |
| CYP2c9-sub | 0.924 |
| CYP2d6-inh | 0.76 |
| CYP2d6-sub | 0.926 |
| CYP3a4-inh | 0.927 |
| CYP3a4-sub | 0.223 |
| CL | 8.978 |
| T12 | 0.371 |
| hERG | 0.041 |
| Ames | 0.206 |
| ROA | 0.051 |
| SkinSen | 0.339 |
| Carcinogencity | 0.916 |
| EI | 0.044 |
| Respiratory | 0.7 |
| NR-Aromatase | 0.665 |
| Antiviral | Yes |
| Prediction | 0.850871 |